Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Superannuation

Super fund targets health tech sector with mandate

Synthesis Capital, the investment arm of the MedTech Actuator, has secured a mandate from a super fund to target startups in deep health technology amid heightened institutional interest in the sector.

Upgrade your subscription to access this article

And gain access to:
  • All website content, including archived news
  • Home page news customisation
  • Tech Zone, your technical resource library
And more
Already A Subscriber?

Read more: Synthesis CapitalHESTAMedTech ActuatorAustralianJeff BruntonAsia-PacificFund IVishaal Kishore